Eicosanoid regulation of the renal vasculature

American Journal of Physiology - Renal Physiology

Volumn 279, Issue 6 48-6, 2000, Pages

  Imig, John D ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Cyclooxygenase; Cytochrome P 450; Endothelial derived hyperpolarizing factor; Endothelin; Lipoxygenase; Nitric oxide; Prostaglandins; Tubuloglomerular feedback

Indexed keywords

ANGIOTENSIN; ICOSANOID; LIPOXYGENASE; NITRIC OXIDE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE;

CORRELATION FUNCTION; ENZYME ACTIVITY; FEEDBACK SYSTEM; GLOMERULUS FILTRATION; HUMAN; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; LIPID PEROXIDATION; PRIORITY JOURNAL; REVIEW;

EID: 0034534288     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2000.279.6.f965     Document Type: Review

References (184)

1. Rat kidney thromboxane receptor: Molecular cloning, signal transduction, and intrarenal expression localization
2. Selective inhibition of 5-lipoxygenase attenuates glomerulonephritis in the rat
3. Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide
4. 20-HETE agonists and antagonists in the renal circulation
5. Contribution of 20-HETE to the vasodilator actions of nitric oxide in renal arteries
6. Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole
7. 20-HETE requires increased vascular tone to constrict rabbit afferent arterioles
8. Glomerular prostaglandins modulate vascular reactivity of the downstream efferent arterioles
9. Importance of prostaglandin E2 (EP) receptors in the control of renal hemodynamics: A study using knockout mice
10. 2
11. Insight into prostaglandin, leukotriene, and other eicosanoid functions using mice with targeted gene disruptions
12. Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney
13. Glomerularnephritis: Roles of lipoxygenase pathways in pathophysiology and therapy
14. Effects of leukotriene D4 on glomerular dynamics in the rat
15. Vasoconstrictor-induced changes in renal blood flow: Role of prostaglandins and histamine
16. 2 in rat renal medullary interstitial cells
17. Renovascular actions of angiotensin II in the isolated kidney of the rat: Relationship to lipoxygenases
18. Differential effect of a selective cyclooxygenase-2 inhibitor versus indomethacin on renal blood flow in conscious volume-depleted dogs
19. Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice
20. 2 receptor expression and ligand binding following immune injury
21. Differential localization of prostaglandin E receptor subtypes in human kidney
22. Functional and molecular aspects of renal prostaglandin receptors
23. Regulation of renal function by prostaglandin E receptors
24. 4 receptor
25. Thromboxane receptors in human kidney tissues
26. Cytochrome P450 and arachidonate cascade
27. Cytochrome P-450 arachidonic acid epoxygenase: Regulatory control of the renal epoxygenase by dietary salt loading
28. Renal vasodilator activity of 5,6-epoxyeicosatrienoic acid depends upon conversion by cyclooxygenase and release of prostaglandins
29. Cyclooxygenase dependency of the renovascular actions of cytochrome P-450-derived arachidonate metabolites
30. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids
31. Prostaglandin interactions with angiotensin, norepinephrine, and thromboxane in rat renal vasculature
32. Renal vascular reactivity to vasodilator prostaglandins in genetically hypertensive rats
33. 2 receptors in the rabbit renal preglomerular vasculature
34. 4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirintriggered lipoxins in reperfusion
35. Leukotrienes and lipoxins: Lipoxygenase-derived modulators of leukocyte recruitment and vascular tone in glomerulonephritis
36. International union of pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes
37. Cellular distribution of cytochrome P-450 in the rat kidney
38. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice
39. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II
40. Signal transduction mechanisms mediating the vascular actions of endothelin
41. 20-Hydroxyeicosatetraenoic acid is an endothelium-dependent vasoconstrictor in rabbit arteries
42. Cytochrome P-450 2C is an EDHF synthase in coronary arteries
43. The endothelium-dependent vasodilator effect of acetylcholine: Characterization of the endothelial relaxing factor with inhibitors of arachidonic acid metabolism
44. Evaluation of prostaglandins as mediators of tubuloglomerular feedback
45. 2-isoprostane receptors on rat vascular smooth muscle cells
46. 2
47. Possible contribution of platelet cyclooxygenase to the renal vascular action of 5,6-epoxyeicosatrienoic acid
48. Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat
49. Effects of indomethacin and iloprost on contraction of afferent arterioles by endothelin-1 in juxtamedullary nephron preparations from normotensive Wistar-Kyoto and spontaneously hypertensive rats
50. Effect of prostaglandin synthesis inhibition on macula densa-stimulated renin secretion
51. Natriuretic response to increased pressure is preserved with COX-2 inhibitors
52. Cloning, expression, and regulation of rabbit cyclooxygenase-2 in renal medullary interstitial cells
53. Cytochrome P450 metabolites of arachidonic acid as intracellular signaling molecules in vascular tissue
54. Cyclooxygenase-2 mediates increased renal renin content induced by low-sodium diet
55. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with slat restriction
56. Impact of cyclooxygenase blockade on juxtamedullary microvascular responses to angiotensin II in rat kidney
57. Direct evidence that thromboxane mimetic U44069 preferentially constricts the afferent arteriole
58. 2 actions in rabbit cortical collecting duct
59. 2 inhibits sodium transport in the rabbit CCD by raising intracellular calcium
60. Inhibition of renin release by 14,15-epoxyeicosatrienoic acid in renal cortical slices
61. 2 receptor
62. Cyclooxygenase-2 participates in tubular flow-dependent afferent arteriolar tone: Interaction with neuronal NOS
63. Cyclooxygenase-2 modulates afferent arteriolar responses to increases in pressure
64. Biosynthesis and metabolism of endothelium-derived nitric oxide
65. Epoxyeicosatrienoic acids: Biosynthesis, regulation and actions
66. 2 receptor deficient mice
67. 2 and modulation by lipoxygenase and P-450 pathways
68. Contribution of cytochrome P450 epoxygenase and hydroxylase pathways to afferent arteriolar autoregulatory responsiveness
69. Afferent arteriolar vasodilation to the sulfonimide analog of 11,12-epoxyeicosatrienoic acid involves protein kinase A
70. Arachidonate metabolites
71. Actions of epoxygenase metabolites on the preglomerular vasculature
72. Cytochrome P450 and cyclooxygenase metabolites contribute to the endothelin-1 afferent arteriolar vasoconstrictor and calcium responses
73. Afferent arteriolar vasoconstriction to 12-hydroxyeicosatraenoic acid involves activation of L-type calcium channels
74. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles
75. Prostaglandin influences on afferent arteriolar responses to vasoconstrictor agonists
76. Eicosanoid modulation of the norepinephrine effect on blood pressure and renal hemodynamics in humans
77. Localization of cytochrome P-450 4A isoforms along the rat nephron
78. Regulation of P-450 4A activity in the glomerulus of the rat
79. 2 interactions in spontaneously hypertensive rats
80. Differential regulation of renal prostaglandin receptor mRNAs by dietary salt intake in the rat
81. Angiotensin II action in isolated microperfused rabbit afferent arterioles is modulated by flow
82. Renal hemodynamic actions of lipoxins in rats: A comparative physiological study
83. Inhibitors of cytochrome P-450 attenuate the myogenic response of dog renal arcuate arteries
84. 2, 12-lipoxygenase, and cyclooxygenase inhibitors in the feline pulmonary bed
85. 2 receptor
86. 2 receptor alpha isoform (TPα) functionally couples to the G proteins G(q) and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F(2α)
87. Calcium dependent synthesis of vasodilator renal microvascular prostanoids
88. Generation of the isoprostane 8-epi-prostaglandin F(2α) in vitro and in vivo via the cyclooxygenases
89. Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: Implication for renal function
90. Systemic inhibition of nitric oxide and prostaglandins in volume-induced natriuresis and hypertension
91. Pathophysiologic role of eicosanoids in mesangial cell immune injury
92. Prostanoid-mediated vascular contraction in normotensive and hypertensive rats
93. Eicosanoids in renal function
94. Molecular cloning, enzymatic characterization, developmental expression, and cellular localization of a mouse cytochrome P450 highly expressed in kidney
95. 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries
96. Effects of 12-HETE on isolated dog renal arcuate arteries
97. Cytochrome P450, the arachidonic acid cascade, and hypertension: New vistas for an old system
98. Arachidonate metabolites and kinins in blood pressure regulation
99. 20-HETE and the kidney: Resolution of old problems and new beginnings
100. Eicosanoids and control of mesangial cell contraction
101. 4 in human kidney
102. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
103. 2-isoprostanes) are formed in situ on phospholipids
104. 2-isoprostanes) in carbon tetrachloride hepatotoxicity: An animal model of lipid peroxidation
105. Noncyclooxygenase oxidative formation of a series of novel prostaglandins: Analytical ramifications for measurements of eicosanoids
106. Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis
107. Role of the lipoxygenase pathway in angiotensin II-induced vascular smooth muscle cell hypertrophy
108. 2-isoprostane in vascular smooth muscle cells by elevated glucose and growth factors
109. 1 analog and prostacyclin in humans
110. Paracrine regulation of the renal microcirculation
111. Prostanoid receptors and their biological actions
112. Eicosanoid regulation of angiogenesis: Role of endothelial arachidonate 12-lipoxygenase
113. 4 in acute renal ischemic-reperfusion injury
114. Inhibition of lipoxygenase pathway reduces blood pressure in renovascular hypertensive rats
115. 2 and thrombin receptors in human platelets
116. Age-related changes in renal cytochrome P-450 arachidonic acid metabolism in spontaneously hypertensive rats
117. Renal oxygenases: Differential contribution to vasoconstriction induced by ET-1 and ANG II
118. Cytochrome P-450 derived eicosanoids participate in the renal functional effects of ET-1 in the anesthetized rat
119. Renal cytochrome P450 ω-hydroxylase and epoxygenase activity are differentially modified by nitric oxide and sodium chloride
120. Estimated rate of thromboxane secretion into the peripheral circulation of normal humans
121. 4 and bradykinin evoke endothelium-dependent relaxation of the renal vein: Dissimilar mechanisms
122. 4-evoked relaxation in canine renal artery
123. Feedback pressure-flow responses in normal and angiotensin-prostaglandinblocked rats
124. Endothelin receptors and calcium signaling
125. Local amplification of platelet function by 8-epi prostaglandin F(2α) is not mediated by thromboxane receptor isoforms
126. Prostaglandins buffer ANG II-mediated increases in cytosolic calcium in preglomerular VSMC
127. The role of the cytochrome P450-dependent metabolites of arachidonic acid in blood pressure regulation and renal function
128. 2 receptor
129. P-450 eicosanoids: A novel signaling pathway regulating renal function
130. Cytochrome P450 metabolites of arachidonic acid in the control of vascular tone
131. Influence of prostaglandins on papillary blood flow and pressure-natriuresis response
132. Mechanisms underlying pressure-related natriuresis: The role of the renin-angiotensin and prostaglandin systems
133. Role of angiotensin and oxidative stress in essential hypertension
134. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects
135. 2 receptor and Gs protein stimulation of cAMP formation in preglomerular vessels of young SHR
136. 2-isoprostane production and cytolysis in renal tubular epithelial cells
137. Influence of isoprostanes on vasoconstricter effects of noradrenaline and angiotensin II
138. Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor
139. Evidence against a role of arachidonic acid metabolites in autoregulatory responses of the isolated perfused rat kidney
140. Angiotensin II and eicosanoids in the control of glomerular size in the rat and human
141. Vascular biology of endothelin
142. Prostaglandins and other arachidonic acid metabolites in the kidney
143. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-iso prostaglandin F(2α)
144. Participation of renal cortical prostaglandins in the regulation of glomerular filtration rate
145. Vasoconstrictor responses in thromboxane receptor knockout mice: Tubuloglomerular feedback and ureteral obstruction
146. Endothelin-mediated calcium signaling in preglomerular smooth muscle cells
147. Endogenous non-cyclooxygenase metabolites of arachidonic acid modulate growth and mRNA levels of immediate-early response genes in rat mesangial cells
148. 2 abrogates endothelin induced vasoconstriction in renal outer medullary descending vasa recta of rat
149. Chronic thromboxane synthase inhibition with CGS 12970 in human cyclosporine nephrotoxicity
150. Modulation of thromboxane receptor activation in rat glomerular mesangial cells
151. Distinct cellular localization of mRNAs for three subtypes of prostaglandin E receptor in kidney
152. + channel activity and vascular tone in renal arterioles
153. Role of tyrosine kinase and PKC in the vasoconstrictor response to 20-HETE in renal arterioles
154. + channel activity and the vasoconstrictor effect of angiotensin II in rat renal arterioles
155. The leukotriene B4 receptor antagonist ONO-4057 inhibits nephrotoxic serum nephritis in WKY rats
156. Cytochrome P-450 arachidonate metabolites in rat kidney: Characterization and hemodynamic responses
157. Glomerular actions of a free radical-generated novel prostaglandin, 8-epiprostaglandin F(2α), in the rat
158. 2 receptor mRNA along mouse nephron segments by RT-PCR
159. Role of eicosanoids in vasopressin-induced calcium mobilization in A 7r5 vascular smooth muscle cells
160. 4 receptor
161. Inhibition of macula densa-stimulated renin secretion by pharmacological blockade of cyclooxygenase-2
162. Arachidonic acid diols produced by cytochrome P-450 monooxygenases are incorporated into phospholipids of vascular endothelial cells
163. 14,15-Epoxyeicosatrienoic acid metabolism in endothelial cells
164. Arachidonic acid metabolism modulates vasopressin-induced renal vasoconstriction
165. 2 on renal function
166. Cysteinylleukotriene receptors in pulmonary vessels
167. Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: Characterization of selective inhibitors
168. Contribution of cytochrome P-450 4A1 and 4A2 to vascular 20-hydroxyeicosatetraenoic acid synthesis in rat kidneys
169. Cloning, sequencing, and cDNA-directed expression of the rat renal CYP4A2: Arachidonic acid ω-hydroxylation and 11,12-epoxidation by CYP 4A2
170. 2 receptor from renal medulla with a pertussis toxin-reactive guanine nucleotide regulatory protein
171. Feedback responses during sequential inhibition of angiotensin and thromboxane
172. Potentiation of tubuloglomerular feedback in the rat by thromboxane mimetic: Role of macula densa
173. Nitric oxide synthase in macula densa regulates glomerular capillary pressure
174. Inhibition of the renin-angiotensin system upregulates cyclooxygenase-2 expression in the macula densa
175. Post-receptor signal transduction and regulation of 14(R),15(S)-epoxyeicosatrienoic acid (14,15-EET) binding in U-937 cells
176. 14(R),15(S)-Epoxyeicosatrienoic acid (14(R),15(S)-EET) receptor in guinea pig mononuclear cell membranes
177. Relative roles of nitric oxide and cylco-oxygenase and lipoxygenase products of arachidonic acid in the contractile response of rat renal arcuate arteries
178. Regulation of cyclooxygenase expression in the rat kidney by dietary salt intake
179. Effect of angiotensin II on isolated rabbit afferent arterioles
180. CYP2J subfamily of P450s in the lung: Expression, localization, and potential functional significance
181. + channel in renal arterioles
182. +-channel activity
183. Effect of P-450 ω-hydroxylase metabolites of arachidonic acid on tubuloglomerular feedback
184. Effects of 17-octadecynoic acid, a suicide-substrate inhibitor of cytochrome P450 fatty acid ω-hydroxylase, on renal function in rats